The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis


Applying different technologies to monitor disease activity and treatment efficacy are essential in a complex disease such as multiple sclerosis. Combining current assays with flow cytometry could create a powerful tool for such analyses. The cell surface expression level of CD74, the MHC class II invariant chain, is a potential disease biomarker that could… (More)
DOI: 10.1007/s11011-014-9634-0


5 Figures and Tables

Slides referencing similar topics